EIIS Investment Opportunity 2021

GlycoSeLect offers qualifying taxpayers the opportunity to invest in the development of tools for medical research and the biopharmaceutical industry through the Employment and Investment Incentive Scheme (EIIS).

  • Qualifying Company
  • Proven Technology
  • Strong Management Team
  • Avail of up to 40% income tax relief
  • Minimum Investment €5,000
  • No entry or exit fees

Contact us now to learn more about investment opportunities at GlycoSeLect.

EIIS investement biopharmaceutical
Menu